Viking Therapeutics, Inc. (VKTX) SEC filings
VKTX SEC filings moved a median of +1.55% by the close. VKTX SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the VKTX overview →
55 measured VKTX SEC filing events.
Where these VKTX SEC filings landedvs 54 measured VKTX SEC filing reactions
| Middle 50% of VKTX SEC filing reactions | -1.65% to +8.93% |
|---|---|
| Median reaction (to close) | +1.55% |
| Measured reactions | 54 |
Point-in-time · zero look-ahead
Half of the 54 VKTX SEC filing events with a measured close landed between -1.65% and +8.93%; 61% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Viking Therapeutics, For: Sep 23 | SEC filing · Form 8-K | +0.35% | -3.93% | |
| Form 305B2 Viking Therapeutics, | SEC filing · Form 305B2 | -1.83% | +1.72% | |
| Form 8-K Viking Therapeutics, For: Sep 22 | SEC filing · Form 8-K | -0.04% | +10.40% | |
| Form S-3ASR Viking Therapeutics, | SEC filing · Form S-3ASR | -4.95% | -1.22% | |
| Form 10-Q Viking Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -4.95% | -1.22% | |
| Form 8-K Viking Therapeutics, For: Jul 29 | SEC filing · Form 8-K | -4.95% | -1.22% | |
| Form 8-K Viking Therapeutics, For: May 19 | SEC filing · Form 8-K | -1.66% | +1.15% | |
| Form 10-Q Viking Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -2.71% | +2.30% | |
| Form 8-K Viking Therapeutics, For: Apr 29 | SEC filing · Form 8-K | -2.71% | +2.30% | |
| Form ARS Viking Therapeutics, For: Dec 31 | SEC filing · Form ARS | +1.00% | +8.41% | |
| Form DEF 14A Viking Therapeutics, For: May 19 | SEC filing · Form DEF | +1.00% | +8.41% | |
| Form DEFA14A Viking Therapeutics, | SEC filing · Form DEFA14A | +1.00% | +8.41% | |
| Form 10-K Viking Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -3.47% | -10.32% | |
| Form 8-K Viking Therapeutics, For: Feb 11 | SEC filing · Form 8-K | -3.47% | -10.32% | |
| Form 10-Q Viking Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -1.13% | -4.29% | |
| Form 8-K Viking Therapeutics, For: Oct 22 | SEC filing · Form 8-K | -1.13% | -4.29% | |
| Form 8-K Viking Therapeutics, For: Aug 19 | SEC filing · Form 8-K | -2.27% | — | |
| Form 10-Q Viking Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +6.95% | +6.35% | |
| Form 8-K Viking Therapeutics, For: Jul 23 | SEC filing · Form 8-K | +6.95% | +6.35% | |
| Form 8-K Viking Therapeutics, For: May 20 | SEC filing · Form 8-K | +0.00% | -0.07% | |
| Form 10-Q Viking Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -0.36% | -0.60% | |
| Form 8-K Viking Therapeutics, For: Apr 18 | SEC filing · Form 8-K | -2.68% | -1.65% | |
| Form 8-K Viking Therapeutics, For: Apr 23 | SEC filing · Form 8-K | -2.68% | -1.65% | |
| Form DEFA14A Viking Therapeutics, | SEC filing · Form DEFA14A | -2.68% | -1.65% | |
| Form DEFR14A Viking Therapeutics, | SEC filing · Form DEFR14A | -2.68% | -1.65% | |
| Form ARS Viking Therapeutics, For: Dec 31 | SEC filing · Form ARS | -0.26% | +17.68% | |
| Form DEF 14A Viking Therapeutics, For: May 20 | SEC filing · Form DEF | -0.26% | +17.68% | |
| Form DEFA14A Viking Therapeutics, | SEC filing · Form DEFA14A | -0.26% | +17.68% | |
| Form 8-K Viking Therapeutics, For: Mar 10 | SEC filing · Form 8-K | -2.87% | +1.61% | |
| Form 10-K Viking Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +2.17% | +1.88% | |
| Form 8-K Viking Therapeutics, For: Feb 05 | SEC filing · Form 8-K | -0.34% | +1.42% | |
| Form 8-K Viking Therapeutics, For: Nov 04 | SEC filing · Form 8-K | -3.90% | -19.33% | |
| Form 10-Q Viking Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -2.21% | +11.36% | |
| Form 8-K Viking Therapeutics, For: Oct 23 | SEC filing · Form 8-K | -2.21% | +11.36% | |
| Form 10-Q Viking Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -0.79% | +9.11% | |
| Form 8-K Viking Therapeutics, For: Jul 24 | SEC filing · Form 8-K | -0.79% | +9.11% | |
| Form 8-K Viking Therapeutics, For: Jun 04 | SEC filing · Form 8-K | -2.55% | -13.49% | |
| Form 8-K Viking Therapeutics, For: May 21 | SEC filing · Form 8-K | -1.11% | -3.57% | |
| Form S-8 POS Viking Therapeutics, | SEC filing · Form S-8 | -1.11% | -3.57% | |
| Form S-8 Viking Therapeutics, | SEC filing · Form S-8 | -1.11% | -3.57% | |
| Form S-8 POS Viking Therapeutics, | SEC filing · Form S-8 | -1.11% | -3.57% | |
| Form 10-Q Viking Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +1.09% | +9.30% | |
| Form 8-K Viking Therapeutics, For: Apr 24 | SEC filing · Form 8-K | +1.09% | +9.30% | |
| Form ARS Viking Therapeutics, For: Dec 31 | SEC filing · Form ARS | -0.44% | +0.60% | |
| Form DEF 14A Viking Therapeutics, For: May 21 | SEC filing · Form DEF | -0.44% | +0.60% | |
| Form DEFA14A Viking Therapeutics, | SEC filing · Form DEFA14A | -0.44% | +0.60% | |
| Form 8-K Viking Therapeutics, For: Mar 26 | SEC filing · Form 8-K | +1.57% | +4.26% | |
| Form 8-K Viking Therapeutics, For: Mar 04 | SEC filing · Form 8-K | +1.81% | -2.33% | |
| Form 8-K Viking Therapeutics, For: Feb 28 | SEC filing · Form 8-K | -0.72% | +1.49% | |
| Form 8-K Viking Therapeutics, For: Feb 27 | SEC filing · Form 8-K | -0.41% | +21.90% | |
| Form 10-K Viking Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +5.24% | +12.19% | |
| Form 8-K Viking Therapeutics, For: Feb 07 | SEC filing · Form 8-K | +5.24% | +12.19% | |
| Form S-8 Viking Therapeutics, | SEC filing · Form S-8 | +5.24% | +12.19% | |
| Form 10-Q Viking Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -0.22% | +7.39% | |
| Form 8-K Viking Therapeutics, For: Oct 25 | SEC filing · Form 8-K | -0.22% | +7.39% |
Keep exploring
More VKTX: earnings → · analyst actions → · VKTX overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Pulse Biosciences, Inc (PLSE) | 320 | +0.18% | 55% |
| Voyager Therapeutics, Inc. (VYGR) | 320 | -0.12% | 42% |
| Aptevo Therapeutics Inc. (APVO) | 318 | -0.89% | 34% |
| MATEON THERAPEUTICS (MATN) | 318 | 0.00% | 35% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.